J&J commences in UK the two-dose trial of its potential Covid-19 vaccine candidate
Johnson and Johnson has commenced a recent late-stage trial in Britain on Monday for evaluating and assessing the testing of a two-dose regimen of its potential Covid-19 vaccine candidate in thousands of participating volunteers, as the U.S. based pharmaceutical company makes a move to launch the drug and conduct its trials in other countries as…